1. Home
  2. EVAX vs AIMD Comparison

EVAX vs AIMD Comparison

Compare EVAX & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • AIMD
  • Stock Information
  • Founded
  • EVAX 2008
  • AIMD 1984
  • Country
  • EVAX Denmark
  • AIMD United States
  • Employees
  • EVAX N/A
  • AIMD N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • AIMD Health Care
  • Exchange
  • EVAX Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • EVAX 17.8M
  • AIMD 16.9M
  • IPO Year
  • EVAX 2021
  • AIMD N/A
  • Fundamental
  • Price
  • EVAX $2.94
  • AIMD $3.45
  • Analyst Decision
  • EVAX Strong Buy
  • AIMD
  • Analyst Count
  • EVAX 2
  • AIMD 0
  • Target Price
  • EVAX $10.00
  • AIMD N/A
  • AVG Volume (30 Days)
  • EVAX 71.6K
  • AIMD 88.6K
  • Earning Date
  • EVAX 10-30-2025
  • AIMD 11-05-2025
  • Dividend Yield
  • EVAX N/A
  • AIMD N/A
  • EPS Growth
  • EVAX N/A
  • AIMD N/A
  • EPS
  • EVAX N/A
  • AIMD N/A
  • Revenue
  • EVAX $3,176,000.00
  • AIMD $110,870.00
  • Revenue This Year
  • EVAX N/A
  • AIMD N/A
  • Revenue Next Year
  • EVAX $425.50
  • AIMD N/A
  • P/E Ratio
  • EVAX N/A
  • AIMD N/A
  • Revenue Growth
  • EVAX 1042.45
  • AIMD 70.25
  • 52 Week Low
  • EVAX $1.20
  • AIMD $2.00
  • 52 Week High
  • EVAX $17.20
  • AIMD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 52.53
  • AIMD 49.78
  • Support Level
  • EVAX $2.81
  • AIMD $3.28
  • Resistance Level
  • EVAX $3.04
  • AIMD $3.83
  • Average True Range (ATR)
  • EVAX 0.20
  • AIMD 0.27
  • MACD
  • EVAX -0.01
  • AIMD -0.06
  • Stochastic Oscillator
  • EVAX 71.19
  • AIMD 18.68

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: